ROLE OF NONSTRUCTURAL PROTEINS IN PESTIVIRUS ASSEMBLY
ROLE OF NONSTRUCTURAL PROTEINS IN PESTIVIRUS ASSEMBLY
批准号:
7715843
负责人:
Arash Grakoui
金额:
$3.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2009-04-30
关键词:
AffectApoptosisCell SurvivalCellsChimera organismCodeComputer Retrieval of Information on Scientific Projects DatabaseCultured CellsEngineeringFundingGenesGenomeGenotypeGrantHepatitis C virusInfectionInfectious hepatitidesInstitutionLengthMutationNonstructural ProteinNucleotidesPestivirusPliabilityProcessProductionProteinsRecombinantsReportingResearchResearch PersonnelResourcesRoleSourceTranslationsUnited States National Institutes of HealthViralVirionVirusVirus Replicationcell growthparticleviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The full-length hepatitis C virus (HCV) JFH1 genome (genotype 2a) has been shown to produce moderate titers of infectious particles in cell culture but the optimal determinants required for virion production are unclear. It has been previously shown that intragenotypic recombinants that encode from core up to NS2 from J6CF in the context of JFH1 are more robust in the release of viral particles.
To understand the contributions of structural and nonstructural genes to HCV replication potential and infectivity, we have characterized several intragenotypic recombinant genotype 2a viruses with different portions of the J6 isolate engineered into the JFH1 infectious clone. All genomes produced high levels of intracellular HCV RNA and NS3 protein in Huh7.5 transfected cells. However, JFH1 genomes containing J6 sequences from C to E2 (CE2) or C to p7 (Cp7) secreted up to 100-fold more infectious HCV particles than the parental JFH1 clone. Subsequent infection of na¿ve Huh7.5 cells with each of the J6/JFH1 recombinants at a multiplicity of infection of 0.0003 resulted in high viral titers only for CE2 and Cp7 viruses. Comparison of virion production by the Cp7 J6/JFH1 recombinant to previously described J6/JFH1 recombinants showed flexibility of the chimeric junction.
Moreover NTRNS2 chimeric virus, which is equivalent to the previously reported FL-J6/JFH chimera, showed a 10- fold enhancement of virus titers compared to CNS2. Since there were no significant differences in terms of translation and replication between these two clones, it is possible that these three mutations may affect post-translational processes leading to an increase in virion production. Sequence comparisons between these two clones showed that NTRNS2 had three nucleotide differences that differed from CNS2. These mutations residing in the 5'NTR and core coding sequence had no effect on virion production.
Importantly, we demonstrated that cells replicating and producing Cp7 virus showed decreased cell growth and increased apoptosis compared with JFH1, an effect that correlated with robust virion production. These studies begin to unravel the requirements for robust virus replication and the relationship between increased virion production and host cell viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10393614
-
项目类别:
-
资助金额:$204.03万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10393615
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10205764
-
项目类别:
-
资助金额:$201.88万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10205768
-
项目类别:
-
资助金额:$73.75万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10393618
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10608110
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10608105
-
项目类别:
-
资助金额:$205.42万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10205765
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10608106
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10063938
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10305612
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
T cell compartmentalization and antiviral response
-
批准号:9127649
-
项目类别:
-
资助金额:$64.13万
-
财政年份:2016
-
负责人:Arash Grakoui
-
依托单位:
DEFINING THE INTRAHEPATIC IMMUNE RESPONSE TO HEPATITIS C VIRUS
-
批准号:8357563
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2011
-
负责人:Arash Grakoui
-
依托单位:
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
-
批准号:8357445
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2011
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8250010
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:7781668
-
项目类别:
-
资助金额:$43.72万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE
-
批准号:8172414
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
-
批准号:8172391
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8050079
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8460497
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: